A preliminary study conducted by Miraglia del Giudice et al. reported encouraging outcomes in alleviating nasal inflammation, as seen in other inflammatory conditions that could elevate Intercellular Adhesion Molecule-1 (ICAM-1) expression and susceptibility to viral infections. This evidence concerns the gene ICAM1 and viral infectious disease.